Comparative Effectiveness and Safety of Cognitive Enhancers for Treating Alzheimer's Disease: Systematic Review and Network Metaanalysis-Reference-Cited by-同舟云学术

Comparative Effectiveness and Safety of Cognitive Enhancers for Treating Alzheimer's Disease: Systematic Review and Network Metaanalysis

Published:2017-09-29 Issue:1 Volume:66 Page:170-178
ISSN:0002-8614
Container-title:Journal of the American Geriatrics Society
language:en
Short-container-title:J Am Geriatr Soc

Author:

Tricco Andrea C.¹²,Ashoor Huda M.¹,Soobiah Charlene¹³,Rios Patricia¹,Veroniki Areti Angeliki¹,Hamid Jemila S.¹⁴,Ivory John D.¹,Khan Paul A.¹,Yazdi Fatemeh¹,Ghassemi Marco¹,Blondal Erik¹³,Ho Joanne M.¹,Ng Carmen H.¹,Hemmelgarn Brenda⁵⁶,Majumdar Sumit R.⁷,Perrier Laure⁸,Straus Sharon E.¹⁹

Affiliation:

1. Li Ka Shing Knowledge Institute St. Michael's Hospital Toronto Ontario Canada

2. Epidemiology Division Dalla Lana School of Public Health University of Toronto Toronto Ontario Canada

3. Institute for Health Policy Management and Evaluation University of Toronto Toronto Ontario Canada

4. Clinical Epidemiology and Biostatistics McMaster University Hamilton Ontario Canada

5. Department of Medicine University of Calgary Calgary Alberta Canada

6. Department ofCommunity Health Sciences University of Calgary Calgary Alberta Canada

7. Department of Medicine University of Alberta Edmonton Alberta Canada

8. Gerstein Science Information Centre University of Toronto Toronto Ontario Canada

9. Division of Geriatric Medicine Department of Medicine University of Toronto Toronto Ontario Canada

Funder

University of Alberta

University of Toronto

Publisher

Wiley

Subject

Geriatrics and Gerontology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgs.15069

Reference44 articles.

1. PrinceM JacksonJ.Alzheimer's disease international: world Alzheimer report 2009[on‐line]. Available athttp://www.alz.co.uk/research/world-reportAccessed July 27 2017.

2. A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease–– rivastigmine patchversus capsule

3. Alzheimer's Disease

4. Effects of 6‐months treatment with donepezil and rivastigmine on results of neuropsychological tests of MMSE, NPI, CLOCK and BENDER in patients with Alzheimer's disease;Abolfazli R;Acta Med Iran,2008

5. Mechanism of action of memantine

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Cognitive Function in Managing People with Diabetes;Textbook of Diabetes;2024-01-12

2. Liposomes as carrier for drug delivery in Alzheimer's disease;Alzheimer's Disease and Advanced Drug Delivery Strategies;2024

3. Patterns of use of symptomatic treatments for Alzheimer's disease dementia (AD);BMC Neurology;2023-11-09

4. Psychiatric Adverse Events of Acetylcholinesterase Inhibitors in Alzheimer’s Disease and Parkinson’s Dementia: Systematic Review and Meta-Analysis;Drugs & Aging;2023-09-08

5. Organophospate-Induced Pathology: Mechanisms of Development, Principles of Therapy and Features of Experimental Studies;Journal of Evolutionary Biochemistry and Physiology;2023-09